Business
Down 53%! Bell Potter says this beaten down ASX 200 stock is a buy
Image source: Getty Images
Telix Pharmaceuticals Ltd (ASX: TLX) shares had another day to forget on Thursday.
The ASX 200 stock ended the day 19% lower at $14.95.
This means that the radiopharmaceuticals company’s shares are now down a sizeable 53% from their 52-week high.
Is this a buying…
Continue Reading
-
Business24 hours agoDown more than 20% this year, does Macquarie rate Boss Energy shares a buy?
-
Noosa News23 hours agoAustralian apple growers gain easier access to Canadian market
-
Business13 hours agoWhy did Pilbara Minerals shares rocket 50%+ in August?
-
Noosa News21 hours agoNewborn’s fatal heart defect mistaken for lung disease